Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis

作者：Chang Tara I^*; Zheng Yuanchao; Montez Rath Maria E; Winkelmayer Wolfgang C

来源：Clinical Journal of the American Society of Nephrology, 2016, 11(8): 1401-1412.

DOI：10.2215/CJN.10611015

Background and objectives The transition from CKD to ESRD can be particularly unstable, with high rates of death and hospitalizations. Few studies have examined medication use during this critical period. We examined patterns of antihypertensive medication use from the four quarters before and eight quarters after incident ESRD treated with maintenance dialysis.
Design, setting, participants, & measurements We used the US Renal Data System to identify patients aged >= 67 years initiating dialysis for ESRD between January 2008 and December 2010 with Medicare Part D and a low-income subsidy. We ascertained the incidence of AKI and hyperkalemia during each quarter on the basis of having at least 1 payment claim for the condition. We used Poisson regression with robust SEMs to formally test for changes in the trend and level of antihypertensive medication use in a series of intervention analyses.
Results The number of antihypertensive drugs used increased as patients neared ESRD, peaking at an average of 3.4 in the quarter immediately preceding dialysis initiation, then declining to 2.2 medications by 2 years later. Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use was stable at approximately 40%, even among patients with coronary disease and systolic heart failure, and did not correlate with AKI or hyperkalemia. Dialysis initiation was associated with a 40%(95% confidence interval, 38% to 43%) lower adjusted level of diuretic use, which continued to decline after ESRD. Three-and four-drug combinations that included a diuretic were most common before ESRD, whereas after ESRD, one-and two-drug beta-blocker or calcium-channel blocker-based combinations were most common.
Conclusions The use of antihypertensive medications, particularly angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and diuretics, may be suboptimal during the transition from CKD to ESRD, especially in patients with coronary disease or systolic heart failure. Future studies are needed to identify strategies to increase the appropriate use of antihypertensive medications during this critical transition period.

• 出版日期2016-8